Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pill hopes to boost blood in bone marrow disease

NCT ID NCT07052006

Ongoing Disease control Sponsor: Halia Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental drug, HT-6184, in adults with a bone marrow disorder called myelodysplastic syndrome (MDS) who have low red blood cell counts (anemia). The goal is to see if the drug can improve blood counts and reduce the need for transfusions. Participants take the drug for up to 32 weeks and are monitored for safety and response.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEMIA IN MYELODYSPLASTIC SYNDROMES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myelodysplastic syndrome Myelodysplastic Syndromes myelodysplastic/myeloproliferative neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANEMIA IN MYELODYSPLASTIC SYNDROMES MYELODYSPLASTIC SYNDROME

Contacts and locations

Locations

  • All India Institute of Medical Sciences

    Dehradun, Rishkesh, 249203, India

  • Apollo Cancer Centre

    Hyderabad, Telangana, 500033, India

  • Dr. Bafna's Star Superspeciality Clinic and Hospital

    Kolhāpur, Maharashtra, 416005, India

  • HCG Cancer Center Vizag

    Visakhapatnam, Krishna, 530040, India

  • Hemato Oncology Clinica Ahmedabad Pvt. Ltd. Vedanta Institute of Medical Sciences

    Ahmedabad, Gujarat, 380009, India

  • Malabar Cancer Center

    Kannur, Kerala, 670103, India

  • Meenakshi Mission Hospital and Research Centre

    Madurai, Tamil Nadu, 625107, India

  • Nil Ratan Sircar Medical College and Hospital

    Kolkata, West Bengal, 700014, India

  • Shalby Hospital

    Ahmedabad, Gujarat, 380015, India

  • Tata Medical Center

    Kolkata, West Bengal, 700160, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.